Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. europe
  4. vascular endothelial
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Albania
  • Andorra
  • Austria
  • Belarus
  • Belgium
  • Bosnia & Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Faroe Islands
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Kosovo
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macedonia
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • Northern Ireland
  • Norway
  • Poland
  • Portugal
  • Romania
  • San Marino
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • Vatican City
Brands

  • ikarovec
  • imedos
  • lvd biotech
  • lys
  • ncardia

Vascular Endothelial Equipment Supplied In Europe

7 equipment items found
In EuropeAvailable In EuropeNear Europe

Ncardia - Human iPSC-Derived Vascular Endothelial Cells

Ncardia - Human iPSC-Derived Vascular Endothelial Cells

Manufactured by:Ncardia Services B.V.   based inLeiden, NETHERLANDS
Vascular endothelial cells are involved in multiple processess including blood flow, vascular permeability or angiogenesis. Our team can manufacture endothelial cells from the iPSC line that best fits your project with a controlled and scalable process. Custom assays can be developed with this fully functional cell model to ...
CONTACT SUPPLIER

Avastin (Bevacizumab)

Avastin (Bevacizumab)

by:F. Hoffmann-La Roche Ltd.    based inBasel, SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
CONTACT SUPPLIER

Retinal Pigment Epithelium (RPE)

Retinal Pigment Epithelium (RPE)

Manufactured by:Newcells Biotech Limited   based inNewcastle Upon Tyne, UNITED KINGDOM
RPE characterisation includes: morphology assessment, pigmentation, RPE-specific expression at the protein level (BEST1, TYRP1), the analysis of phagocytosis of photoreceptor outer segments, trans-epithelial resistance (TEER), polarity of apical Pigment Epithelium-Derived Factors (PEDF) and basal vascular endothelial growth factor (VEGF) ...
CONTACT SUPPLIER

LVD Biotech - Drug-Eluting Stent (DES)

LVD Biotech - Drug-Eluting Stent (DES)

Manufactured by:LVD Biotech   based inSant Vicenç dels Horts, SPAIN
We handle several drugs and have shown controlled release over a prolonged period enabling healing of the surrounding vascular tissue and endothelial layer. ...
CONTACT SUPPLIER

Imedos - Dynamic Vessel Analysis

Imedos - Dynamic Vessel Analysis

Manufactured by:Imedos Health GmbH   based inJena, GERMANY
The aim of dynamic vascular analysis (DVA) is to examine the condition and function of the retinal vessels by measuring their diameter. We measure the vessel diameters because they are the actuators of autoregulation and reflect regulatory effects. With DVA, you can continuously measure these vessel diameters over time at a rate of 25 values per second and stimulate the microcirculation in any ...
CONTACT SUPPLIER

Ikarovec - Diabetic Macular Edema (DME) Biotechnology

Ikarovec - Diabetic Macular Edema (DME) Biotechnology

Manufactured by:Ikarovec   based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. For people with type 2 diabetes, the chance of developing retinopathy after 10 years is between 67% and 80%. DME is caused by blood vessels in ...
CONTACT SUPPLIER

Lys - Model Glunomab / Glunozumab - Monoclonal Antibody

Lys - Model Glunomab / Glunozumab - Monoclonal Antibody

Manufactured by:Lys Therapeutics   based inCAEN, FRANCE
Glunomab / Glunozumab®: a monoclonal antibody counteracting the strong toxicity triggered by the interaction of an endogenous protease, tissue plasminogen activator (tPA) with NMDA receptors ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT